Added to YB: 2023-09-15
Pitch date: 2023-09-15
FIXX [bullish]
Homology Medicines, Inc.
-22.11%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of March 25, 2024, Homology Medicines, Inc. was acquired by Q32 Bio Inc., in a reverse merger transaction.
Market Cap
$54.3M
Pitch Price
$21.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.24
P/E
-0.48
EV/Sales
-23.35
Sector
Biotechnology
Category
N/A
Show full summary:
Homology Medicines: Strategic Alternatives, Potentially Valuable JV
A summary for this pitch has not been created yet.
Read full article (1 min)